Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04036331 · ClinicalTrials.gov registry record · NA

Dyad Plus Effectiveness/Feasibility

A NA study of Weight Loss and Pediatric Obesity, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT04036331: Recruiting NA study of Weight Loss and Pediatric Obesity, sponsored by Wake Forest University Health Sciences.

NCT04036331 is a NA study of Weight Loss and Pediatric Obesity that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 90 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04036331, a NA study of Weight Loss and Pediatric Obesity, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to determine the effectiveness of a coordinated program (Dyad Plus) that would help to facilitate self-monitoring, positive communication, joint problem solving, and social support to increase physical activity, healthy eating, and weight loss. Participants of the Brenner FIT (Families In Training) pediatric weight management program and their parent/guardian will co-enroll in weight loss programs. Parents/guardians will receive the components of By Design Essentials.

Primary Outcome

Weight status of caregivers and youth will be quantified through calculation of BMI derived from measurement of height and weight at the intake and follow-up visits. Both height (plus or minus 0.1 cm) and weight (plus or minus 0.5 kg) will be recorded twice and values will be averaged to produce the final value using a Tanita (registered trademark) digital scale and a Seca (registered trademark) Height Rod (respectively). BMI will be calculated as kg /m2. BMI z-score will be calculated using CDC

Conditions Studied

Weight Loss Pediatric Obesity Parent-Child Relations Overweight Adolescents Family and Household

Interventions

  • BEHAVIORAL Brenner FIT Standard
  • BEHAVIORAL By Design Essentials
  • BEHAVIORAL Dyad Plus

Study Locations (1)

North Carolina

  • Wake Forest Baptist Medical Center - Winston-Salem

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2021-07-30
Est. Completion 2026-03
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What NCT04036331 shows while recruiting

NCT04036331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (94% lower).

The record links to 5 conditions, with Weight Loss appearing as the primary indexed condition, and to 3 interventions - of which Brenner FIT Standard is the first listed.

NCT04036331 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04036331 about?

NCT04036331 is a clinical study titled "Dyad Plus Effectiveness/Feasibility". The purpose of this research is to determine the effectiveness of a coordinated program (Dyad Plus) that would help to facilitate self-monitoring, positive communication, joint problem solving, and social support to increase physical activity, healthy eating, and weight loss. Participants of the Bre...

What is the current status of trial NCT04036331?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2021-07-30. Estimated completion is 2026-03.

What conditions does trial NCT04036331 study?

This clinical trial studies the following conditions: Weight Loss, Pediatric Obesity, Parent-Child Relations, Overweight Adolescents, Family and Household.

What interventions are being tested in trial NCT04036331?

The interventions under investigation include: Brenner FIT Standard (BEHAVIORAL), By Design Essentials (BEHAVIORAL), Dyad Plus (BEHAVIORAL).

Who is sponsoring clinical trial NCT04036331?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04036331 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Weight Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04036331's enrollment target sits among peer trials

90 54th of 116 higher than 62 of 116 other Weight Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT04036331

Source: ClinicalTrials.gov NCT04036331, the US trial registry maintained by the National Library of Medicine. NCT04036331 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.